Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death in western countries. The major risk factors for HCC are hepatitis C or B viruses, alcohol and metabolic disorders. The increasing risk of HCC in patients with metabolic disorders (i.e. obesity, diabetes and non-alcoholic steatohepatitis/NASH) regardless of the presence of liver cirrhosis is becoming relevant. Nevertheless, molecular mechanisms linking these risk factors to liver oncogenesis are unclear. This review focuses on the pathogenic role of the lysophosphatidic acid (LPA) pathway in HCC, highlighting the implications of this bioactive phospholipid in liver cancer biology and metabolism and as potential therapeutic target.
Implications of the lysophosphatidic acid signaling axis in liver cancer / C. Lopane, P. Agosti, I. Gigante, C. Sabbà, A. Mazzocca. - In: BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. - ISSN 0304-419X. - 1868:1(2017), pp. 277-282.
Titolo: | Implications of the lysophosphatidic acid signaling axis in liver cancer |
Autori: | |
Parole Chiave: | Autotaxin (ATX); Hepatocellular carcinoma (HCC); LPA receptors (LPARs); Lysophosphatidic acid (LPA); Oncogenesis; Signaling pathway; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Lysophospholipids; Phospholipids; Risk Factors; Signal Transduction; Oncology; Genetics; Cancer Research |
Settore Scientifico Disciplinare: | Settore MED/09 - Medicina Interna Settore MED/05 - Patologia Clinica Settore MED/06 - Oncologia Medica |
Data di pubblicazione: | 2017 |
Rivista: | |
Tipologia: | Article (author) |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1016/j.bbcan.2017.06.002 |
Appare nelle tipologie: | 01 - Articolo su periodico |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
1-s2.0-S0304419X17300999-main.pdf | Publisher's version/PDF | Administrator Richiedi una copia |